Consecutive Controlled Case Series on Effectiveness of Opipramol in Severe Sleep Bruxism Management—Preliminary Study on New Therapeutic Path

Background: Sleep bruxism (SB) management aims to reduce the number and magnitude of bruxism episodes per hour of a patient’s sleep and, therefore, reduce the potentially negative clinical consequences. Opipramol belongs to the group of tricyclic antidepressants (TCAs) and is considered as an atypic...

Full description

Bibliographic Details
Main Authors: Mieszko Wieckiewicz, Helena Martynowicz, Tomasz Wieczorek, Anna Wojakowska, Katarzyna Sluzalec-Wieckiewicz, Pawel Gac, Rafal Poreba, Grzegorz Mazur, Efraim Winocur, Joanna Smardz
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Brain Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3425/11/2/146